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Abstract 
Background: This study examines the prevalence of drug resistance in gastrointestinal nematodes to macrocyclic 
lactones (ML) and benzimidazoles (BZ) in Lithuanian sheep using sensitive and precise in vitro methods. The sur-
vey was conducted from August 2013 to November 2014. Thirty-three farms with sheep previously treated with BZ 
and ivermectin (IVM) were included in the study. On 12 farms where only BZ were used, egg hatch discrimination 
dose testing (EHDDT) was conducted to detect anthelmintic resistance (AR) to BZ. On eight farms where only ML 
were used, micro agar larval development testing (MALDT) was conducted to detect AR to ivermectin (IVM). On the 
remaining 13 farms, where both classes of drugs were used, EHDDT and MALDT were both applied to detect multid-
rug resistance to BZ and IVM.
Results: BZ-resistant gastrointestinal nematodes were found on all 25 farms with a previous history of BZ use. High 
levels of resistance (>40 % of hatching) were recorded on 36 % of these farms, and low levels (<20 % of hatching) 
on 40 % of farms. IVM-resistant populations were found on 13 out of 21 sheep farms using this drug. Of these 13 
farms with AR to IVM, low levels of resistance (<30 % development) were recorded on 84.6 % of farms and high levels 
(>30 % development) on 15.4 % of farms. No resistance to IVM was recorded on 38.1 % of farms. Multi-drug resistance 
was detected on five farms out of 13 (38.5 %) using both classes of drugs.
Conclusions: The present study demonstrates the existence of AR to BZ and ML on Lithuanian sheep farms thus 
confirming results in a previous in vivo study. Cases of multi-drug resistance were recorded in the present study and 
require further consideration. An appropriate strategy for anthelmintic treatment, measures to prevent gastrointes-
tinal nematode infection and a better understanding of the management practices associated with resistance may 
slow down further development of AR.
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Background
Gastrointestinal nematode (GIN) infections remain the 
most prevalent parasitic diseases and are controlled on 
many farms with continuous anthelmintic treatments [1]. 
Sheep farmers mainly use benzimidazoles (BZ) and mac-
rocyclic lactones (ML) for chemotherapy, but overuse 
of anthelmintic drugs leads to the selection of resistant 
parasites [2]. The rate of emergence of resistant strains 
has generally been lower in temperate zones in the north-
ern hemisphere compared with other regions due to dif-
ferent climate, parasite species and treatment frequency 
[3]. However, occurrence of resistance in Europe is 
increasing and anthelmintic resistance (AR) not only to a 
single drug, but resistance to two or even all three major 
anthelmintic groups (multidrug resistance) has also 
been reported [4–6]. AR to both BZ and ML has been 
recorded in the Slovak Republic [7], Spain [8, 9], Italy [10, 
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11], Greece [12], the United Kingdom [13, 14] and the 
Netherlands [15].
AR to BZ is widespread in Europe, with high levels of 
resistance, while AR to ML is relatively low [16]. Low lev-
els of ivermectin (IVM) resistance may be misdetected 
with the current most widely used method, the faecal 
egg count reduction test (FECRT) [17]. The accuracy 
of this method depends on a correlation between egg 
counts and worm burdens, which is not always the case 
[18]. Therefore determination of AR has to be performed 
using more efficient methods, e.g. in vitro tests [1, 19].
In a recent study using FECRT [20], AR was detected 
in 27.8  % of Lithuanian sheep flocks irrespective of the 
anthelmintic used. In that study, 71.8  % of sheep farm-
ers surveyed used anthelmintics against GINs and the 
most commonly used classes of anthelmintics were ML 
(68.6 %; 95 % CI 56.9–8.2), BZ (27.5 %; 95 % CI 18.1–38.6) 
and levamisole (3.9  %; 95  % CI 0.9–9.8) [20]. However, 
information about the prevalence of GIN in Lithuanian 
sheep flocks is limited and the AR reported in  vivo has 
not been confirmed by in vitro methods. The aim of the 
present study was therefore to examine the prevalence of 
drug resistance in GIN species to ML and BZ in Lithu-
anian sheep flocks using cheap, sensitive and precise 
in vitro methods, which also have the potential to detect 
low levels of resistance.
Methods
Trial design
The survey was conducted from August 2013 to Novem-
ber 2014. A total of 33 farms, mainly in central and 
southern Lithuania, were enrolled in the study. All tfarms 
had a history of use of fenbendazole and/or IVM for 
3–5  years and the last anthelmintic treatment was car-
ried out at least 10  weeks before the start of the study. 
On 12 of the 33 farms, where only BZ were used, an egg 
hatch discrimination dose test (EHDDT) was conducted 
for detection of AR to BZ. On eight other farms where 
only ML were used, a micro agar larval development test 
(MALDT) was conducted for detection of AR to IVM. 
On the remaining 13 farms, where both classes of drugs 
were used, both tests were applied to test for multidrug 
resistance to BZ and IVM.
The size of sheep flocks was 40–1000 animals per farm 
and most farms had Lithuanian black-headed sheep 
and crossbreed sheep. On all farms, the animals grazed 
on pasture from April to October. On each farm, fae-
ces samples were taken from the rectum of 15–20 ran-
domly selected animals. Pooled faeces samples weighing 
50–100 g were stored anaerobically in plastic tubes filled 
with water at room temperature and processed during 
the next 2 days [21]. Nematode eggs were isolated by 
sequential sieving of the faeces through three stacked 
sieves with mesh size 20, 100 and 250  µm. The mate-
rial collected on the 20 µm sieve was washed with water 
and sedimented by centrifugation. Trichostrongylid eggs 
were then recovered by the sugar flotation method and 
used for in vitro EHDDT and/or MALDT [22, 23].
The study was performed in compliance with Lithu-
anian animal welfare regulations (No. B1-866, 2012; No. 
XI-2271, 2012) and was approved by the Lithuanian 
Committee of Veterinary Medicine and Zootechnic Sci-
ences (Protocol No.07/2010).
Egg hatch discrimination dose test
To examine AR to BZ, EHDDT was performed as 
described by Coles et al. [24]. A stock solution of thiaben-
dazole (TBZ) (Sigma-Aldrich, Germany) was prepared by 
dissolving the pure compound in dimethyl sulphoxide 
(DMSO) (Sigma-Aldrich, Germany). The final concentra-
tion was prepared by adding 10 µl of the TBZ solution to 
1.99 ml of an aqueous suspension with approximately 150 
eggs/ml [21]. For the purposes of this study, EHDDT was 
only used at the single working concentration of 0.1 µg/
ml. A control, 0.5 % DMSO solution without anthelmin-
tic, was also included in the test. The egg suspensions 
were dispensed into 24-well plates (Nuncleon, Denmark) 
and incubated at 27 °C for 48 h. The test was stopped by 
adding 10 µl of Lugol’s iodine and the first 100 eggs and/
or larvae were counted in each well. The test was per-
formed with two replicates. The results on AR to BZ i 
were interpreted according to the method described by 
Dolinska et al. [21].
Micro‑agar larval development test
The MALDT was performed in 96-well microtitre plates 
as described by Coles et  al. [25]. Ivermectin aglycone 
(IVM-Ag) was chosen for this test because of the higher 
ability to differentiate between the IVM-resistant and 
susceptible isolates [26]. Stock solutions of IVM-Ag were 
serially diluted 1:2 with DMSO to produce 12 concen-
trations ranging from 0.084 to 173.6  ng/ml. Then 12  μl 
of each stock solution with different final concentrations 
were mixed with 150 μl of 2 % Bacto agar (Difco, USA) 
and stored at 4  °C for 5  min. To inhibit fungal growth, 
10  μl of eggs (final number of 50 eggs per well) in a 
0.3  mg/ml solution of amphotericin B (Sigma-Aldrich, 
Germany) were mixed with 10  μl of yeast extract and 
added to the agar [21, 23]. Yeast extract was prepared 
as described by Hubert and Kerboeuf [27]. Only DMSO 
(1.3  %) was used in the control wells. The plates were 
incubated for 7 days at 27 °C. Incubation was terminated 
by adding Lugol’s iodine solution to each well. After 
incubation, the proportions of unhatched eggs, L1–L2 
and L3 stage larvae at each concentration were deter-
mined under an inverted stereomicroscope. For IVM 
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resistance, a threshold discriminating concentration of 
21.6 ng/ml was chosen and the results were interpreted 
according to the method described by Dolinska et al. [26, 
28].
Statistical analysis
The lower and higher limits of the 95 % confidence inter-
val were calculated following WAAVP recommendations 
[24]. Descriptive statistics were calculated using Micro-
soft® Excel 2007 and IBM SPSS Statistics (Version 21.0). 
Differences in the level of resistance to BZs and MLs 
were calculated using Fisher’s exact test, performed using 
GraphPad Prism version 4.00.
Results
Instead of using the conventional threshold values (ED50 
or ED99), the number of hatched eggs at a discrimination 
dose (DD) concentration of 0.1 µg/ml was used, because 
DD prevents 99 % of the susceptible eggs from hatching 
[21]. The percentage of hatched eggs was categorised into 
low, medium or high based on farm status (susceptible/
resistance) determined by hatching in the EHDDT. BZ-
resistant GIN were found in all 25 farms investigated. 
On 36 % of these farms (9/25; 95 % CI 18.0–57.5), a high 
level of resistance (>40  % of hatching) was recorded. A 
medium level of resistance in GIN was recorded on 24 % 
of farms (6/25; 95  % CI 9.4–45.1), while a low level of 
resistance (<20 % of hatching) was recorded on 40 % of 
farms (10/25; 95  % CI 21.1–61.3) (Fig.  1). However the 
differences in incidence of different levels of resistance 
were not significant (P > 0.05).
The results for IVM resistance among GIN deter-
mined using MALDT in vitro on 21 sheep farms are pre-
sented in Fig.  2. On 61.9  % of these farms (13/21; 95  % 
CI 38.4–81.9), L3 larvae had developed at the threshold 
concentration of 21.6  ng/ml. No resistance to IVM was 
detected on 38.1 % of farms (8/21; 95 % CI 18.1–61.6), all 
of which were in the group of farms where both classes 
of anthelmintics were used. The percentage of developed 
L3 larvae at the threshold concentration was categorised 
as low (<30  % development of larvae) or high (>30  %). 
The differences between groups where AR to IVM was 
detected and no resistance to IVM was found were 
not significant (P  >  0.05). A low level of resistance was 
detected on 84.6 % of farms (11/13; 95 % CI 54.6–98.1) 
(P < 0.05), while a high level of resistance was recorded 
on 15.4 % of farms (2/13; 95 % CI 1.9–45.4). The differen-
tiation of L3 larvae at the discrimination concentration in 
the MALDT revealed the presence of Teladorsagia/Tri-
chostrongylus spp. in all tests.
Low levels of multidrug resistance were detected on 
five (38.5  %; 95  % CI 13.9–68.4) out of 13 sheep farms. 
From this group, where both classes of anthelmintics 
were used, AR to BZ was found on all farms, while AR to 
IVM-Ag was found on only five out of 13 farms.
Discussion
A previous study on AR on Lithuanian sheep farms 
using in  vivo FECRT reported 20  % (95  % CI 4.3–48.1) 
prevalence of AR to BZ on three out of 15 farms, while 
AR was suspected on one farm (6.7 %; 95 % CI 0.2–31.9) 
[20]. However, the correlation between FECRT and EHT, 
on which detection of BZ resistance is based, is some-
times low [1, 29]. As an alternative, in  vitro methods 
are cheaper, faster, more sensitive and suitable for wide-

























Fig. 1 Number of sheep farms with different percentage levels of 
hatched eggs at a threshold of 0.1 μg/ml thiabendazole detected by 


























Fig. 2 Number of sheep farms with development of larvae at a 
threshold of 21.6 ng/ml ivermectin aglycone detected by MALDT on 
21 farms
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The results from the present in  vitro study show that 
AR to BZ and ML is prevalent on the sheep farms stud-
ied, irrespective of the anthelmintic used. However, 
the results of this in  vitro study and those of the previ-
ous in  vivo study [20] cannot be statistically compared, 
due to different farms being enrolled in the two studies. 
Using in vitro EHDDT, AR to BZ was found on all farms 
studied, but there was no significant difference (P > 0.05) 
between the occurrence of high (36  %), medium (24  %) 
and low (40 %) levels of AR.
Despite the high prevalence of AR to BZ on the Lithu-
anian sheep farms studied, the levels of resistance were 
still low and/or medium (<40 % of hatching). A possible 
explanation for the high prevalence of AR to BZ observed 
on these sheep farms is the long history of BZ availability 
on the Lithuanian market. Lack of rotation of anthelmin-
tics could also be responsible for the increasing develop-
ment of BZ resistance, as anthelmintics were found to 
be rotated on only 4.8 % of sheep farms in the previous 
study [20].
In general, BZ resistance is much more prevalent in 
some, but not all, countries compared with IVM resist-
ance [30]. Studies using different in  vivo and in  vitro 
methods have recorded AR to BZ on 83 % of sheep farms 
examined in western France [18], 11.0 % in Norway [31], 
13.6 % in Spain [6] and 100 % in Slovak Republic [21].
The previous study in Lithuania using in  vivo FECRT 
found AR to IVM on 12.5 % of farms studied [20]. A com-
parable prevalence of AR to IVM, which is much lower 
than the prevalence of AR to BZ, has been reported for 
other European countries [11, 21]. Based on the results of 
the present study, AR to IVM has not yet reached a criti-
cal level as a low level of AR to IVM was recorded on the 
majority of sheep farms (84.6 %; P < 0.05), while a high 
level of AR was only recorded on the remaining 15.4 % of 
farms. No AR to IVM was recorded on over one-third of 
sheep farms (38.1 %). Ivermectin is the most used anthel-
mintic on Lithuanian sheep farms (68.6  %) [20]. The 
lower price of IVM and the easier and faster administra-
tion compared with fenbendazole, which is administered 
orally, are the main reasons for the selection of injectable 
ivermectin on sheep farms [20]. Although IVM is quite a 
new drug used on Lithuanian sheep farms, frequent use 
of IVM in combination with clorsulon for the treatment 
of GIN and Fasciola hepatica in sheep could make some 
contribution to the development of AR to IVM. In addi-
tion to underdosing and lack of rotation of drugs, lack 
of strict quarantine for newly introduced breeding ani-
mals and low knowledge of their treatment history with 
anthelmintics have been recorded. Moreover, knowledge 
about AR, the prevalence of GINs and proper usage of 
anthelmintics is also limited among Lithuanian sheep 
farmers [20].
Data on AR obtained using in  vitro methods can be 
analysed using the conventional threshold values ED50/
LC50 or ED99/LC99 [32]. However, EHDDT and MALDT 
using the ED99/LC99 criterion and the threshold DD 
have the potential to detect low levels of resistance [33], 
although the ED50/LC50 criterion is not able to provide 
early detection during the development of resistance [21]. 
In addition, EHDDT provides a good estimate of geno-
type resistance [34]. Analysing data using a threshold 
discriminating concentration of 0.1  µg/ml for thiaben-
dazole and 21.6 ng/ml for IVM-Ag is faster, simpler and 
inexpensive [26, 28]. In addition, if ED50/LC50 or ED99/
LC99 could be used to describe the results, the number 
of farms with AR would probably decrease, but using the 
DD criterion is more sensitive and can specifically reveal 
a small proportion of resistance in the population.
The multidrug resistance detected in the present study 
is of increasing concern in Lithuania and in many other 
countries. Multidrug resistance has been reported in 
Brazil [35], New Zealand [36], the United Kingdom [37], 
Germany [5] and Spain [6]. The rapid evolution of multi-
ple anthelmintic resistance may lead to total anthelmintic 
failure [1, 38, 39]. The first reported case of resistance to 
monepantel, a novel drug class which first became avail-
able in New Zealand in 2009, is another example of the 
fast development of AR [40, 41].
In the present study, low and/or medium levels of 
multidrug resistance were detected with both tests (e.g. 
16.2  % development of larvae to L3 at a threshold of 
21.6  ng/ml IVM-Ag in MALDT and 14.0  % of hatched 
eggs at a threshold of 0.1  µg/ml TBZ in EHDDT). The 
in vitro tests greatly improved knowledge on the level of 
AR in Lithuanian sheep farms, showing markedly higher 
occurrence of AR than previous reports based on in vivo 
methods [20, 42].
Conclusions
This study demonstrated the existence of resistance to 
BZ and ML on Lithuanian sheep farms, confirming pre-
vious results from in  vivo studies. Cases of multi-drug 
resistance were also demonstrated and require further 
consideration. An appropriate strategy for anthelmintic 
treatment, measures to prevent GIN infections and a bet-
ter understanding of management practices associated 
with resistance could slow the development of resistance.
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